Resmed Inc. RMD

NYS: RMD | ISIN: US7611521078   7/06/2023
214,77 USD (-3,25%)
(-3,25%)   7/06/2023

25 mei 2023 · 3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023 · Persbericht

2 mei 2023 · ResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality Officer · Persbericht

30 maart 2023 · ResMed Chief Administrative Officer and Global General Counsel to Retire · Persbericht

13 maart 2023 · ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep · Persbericht

26 januari 2023 · ResMed Appoints Michael Farrell as Chair of its Board of Directors Peter Farrell to Become Chair Emeritus · Persbericht

22 november 2022 · ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions · Persbericht

4 september 2022 · Over 480 Million People Estimated to Have COPD, World’s Third Deadliest Disease, ResMed Study Reports · Persbericht

28 juni 2022 · ResMed Promotes Lucile Blaise to President, Sleep & Respiratory Care · Persbericht

14 juni 2022 · ResMed to Acquire MEDIFOX DAN, a German Leader in Out-of-Hospital Software Solutions · Persbericht

25 mei 2022 · ResMed Announces Participation in the 38th Annual Bernstein Strategic Decisions Conference · Persbericht

18 mei 2022 · Even 2 Hours of PAP Therapy per Night Benefits Sleep Apnea Sufferers: ResMed Study · Persbericht

5 mei 2022 · ResMed Announces Leadership Change · Persbericht

28 april 2022 · ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2022 · Persbericht

27 april 2022 · ResMed Announces Participation in the 24th Annual Macquarie Australia Conference · Persbericht

7 april 2022 · ResMed to Report Third Quarter Fiscal 2022 Earnings on April 28, 2022 · Persbericht

17 maart 2022 · ResMed Announces Participation in the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum · Persbericht

14 maart 2022 · ResMed’s Global Sleep Surveys Reveal What’s Keeping Us Up at Night; Aim to Bring Awareness to the State of Sleep Health for World Sleep Day · Persbericht

10 maart 2022 · ResMed Announces Participation in the Oppenheimer 32nd Annual Healthcare Conference · Persbericht

1 februari 2022 · ResMed Welcomes Urvashi Tyagi as New Chief Technology Officer · Persbericht

8 september 2021 · People with Sleep Apnea Live Longer on CPAP in Large, Late-Breaking ResMed-Supported ALASKA Study Presented at ERS · Persbericht

Mijn selecties